FDA APPROVES ECHOCATH BLOOD VELOCITY MEASUREMENT UNIT.EchoCath, Inc. (NASD-OTC:ECHTA), Princeton, N.J., has been granted permission by the U.S. Food and Drug Administration to market its EchoFlow(TM) battery powered, portable blood velocity measurement system (EchoFlow PEF-1). EchoFlow PEF-1 is a battery powered and portable angle-independent blood velocity measuring system that enables physicians to evaluate and quantify blood flow in vessels using ultrasound ultrasound or sonography, in medicine, technique that uses sound waves to study and treat hard-to-reach body areas. In scanning with ultrasound, high-frequency sound waves are transmitted to the area of interest and the returning echoes recorded technology. Blood velocity is an important parameter of circulatory system circulatory system, group of organs that transport blood and the substances it carries to and from all parts of the body. The circulatory system can be considered as composed of two parts: the systemic circulation, which serves the body as a whole except for the health. In addition to EchoCath's EchoFlow(TM) BVM-1 system designed for use in the operating room operating room n. Abbr. OR A room equipped for performing surgical operations. for blood velocity measurement, the EchoFlow(TM) PEF-1 extends the usefulness of EchoCath's proprietary ultrasound technology. Intensive care units, dialysis dialysis (dīăl`ĭsĭs), in chemistry, transfer of solute (dissolved solids) across a semipermeable membrane. Strictly speaking, dialysis refers only to the transfer of the solute; transfer of the solvent is called osmosis. facilities and clinics are areas of hospitals where physicians have had the need for accurate blood velocity measurement but have not had cost effective readily available equipment. The EchoFlow(TM) PEF-1 system addresses these needs. EchoCath president, Frank DeBernardis commented, "We are pleased that surgeons who have been using our EchoFlow(TM) BVM-1 in clinical evaluations clinical evaluation Medtalk An evaluation of whether a Pt has symptoms of a disease, is responding to treatment, or is having adverse reactions to therapy have been impressed with the systems and have identified a number of applications for the technology outside of the operating room. The EchoFlow(TM) PEF-1 is EchoCath's response to their input." For more information, call 609/987-8400. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion